Although C1GALT1 controls many cellular behaviors and EGFR serves as a therapeutic target in several malignancies, including HNSCC, lung cancers, and colon cancers, the therapeutic potential of targeting C1GALT1 and its effect on EGFR signaling in HNSCC remain unclear. Here, EGFR is linked to head and neck squamous cell carcinoma.